1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Uzbekistan Pharmaceuticals and Healthcare Report Q4 2016

Uzbekistan Pharmaceuticals and Healthcare Report Q4 2016

  • November 2016
  • -
  • Business Monitor International
  • -
  • 88 pages

Includes 3 FREE quarterly updates


BMI View:

Ongoing economic development and a large population will increase the appeal of the Uzbek healthcare and pharmaceutical sector to foreign companies over the long term. Although most pharmaceutical sub-sectors, including patented products, will observe sales growth over the forecast period, low spending per capita on medicine and the poor regulatory environment mean generic drugs will continue to play a major role in Uzbekistan's drug market in the coming years. While local drug manufacturing and exports will continue to increase, Uzbekistan will remain strongly dependent on drug imports in the foreseeable future.

Headline Expenditure Projections

- Pharmaceuticals: UZS2.78trn (USD956mn) in 2015 to UZS3.19trn (USD1.1bn) in 2016; 14.6% in local currency terms and 11.4% in US dollar terms. Forecast revised upwards compared to the previous quarter.

- Healthcare: UZS9.60trn (USD3.74bn) in 2015 to UZS10.96trn (USD3.66bn) in 2016; 14.2% in local currency terms and -2.1% in US dollar terms. Forecast revised downwards compared to the previous quarter.

Table Of Contents

Uzbekistan Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Uzbekistan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Uzbekistan 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020) 24
OTC Medicines Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Uzbekistan 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Uzbekistan 2014-2020) 30
Industry Risk/Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q4 2016 31
Uzbekistan Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 41
Pricing And Reimbursement 43
Market Overview 45
Healthcare Sector 46
Research And Development 51
Clinical Trials 52
International Cooperation 52
Epidemiology 54
Competitive Landscape 58
Research-Based Industry 59
Table: Multinational Market Activity 59
Generic Drugmakers 60
Table: List Of Companies In Uzpharmsanoat SJSC (as of October 7 2013) 63
Pharmaceutical Distribution 66
Pharmaceutical Retail Sector 67
Company Profile 68
Asklepiy Pharmaceutical Company 68
Jurabek Laboratories 70
Uzpharmsanoat 73
Demographic Forecast 77
Table: Population Headline Indicators (Uzbekistan 1990-2025) 78
Table: Key Population Ratios (Uzbekistan 1990-2025) 78
Table: Urban/Rural Population and Life Expectancy (Uzbekistan 1990-2025) 79
Table: Population By Age Group (Uzbekistan 1990-2025) 79
Table: Population By Age Group % (Uzbekistan 1990-2025) 80
Glossary 82
Methodology 84
Pharmaceutical Expenditure Forecast Model 84
Healthcare Expenditure Forecast Model 84
Notes On Methodology 85
Risk/Reward Index Methodology 86
Index Overview 87
Table: Pharmaceutical Risk/Reward Index Indicators 87
Indicator Weightings 88

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.